Gainers
Hexo Corp (NYSE: HEXO) rose 106.8% to $0.43 in pre-market trading. HEXO’s shareholders, on Tuesday, approved the note transaction with Tilray Brands.
Strengthening Cornerstone Rheumatology™ GPO as a leading rheumatology-focused GPO by providing innovative solutions and robust specialty drug access to over 1,300 rheumatology providers nationwide.
DUBLIN,